» Articles » PMID: 32952996

Characterization of the Genomically Encoded Fosfomycin Resistance Enzyme from

Overview
Journal Medchemcomm
Specialty Chemistry
Date 2020 Sep 21
PMID 32952996
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

belongs to a group of rapidly growing mycobacteria (RGM) and accounts for approximately 65-80% of lung disease caused by RGM. It is highly pathogenic and is considered the prominent Mycobacterium involved in pulmonary infection in patients with cystic fibrosis and chronic pulmonary disease (CPD). FosM is a putative 134 amino acid fosfomycin resistance enzyme from subsp. bolletii that shares approximately 30-55% sequence identity with other vicinal oxygen chelate (VOC) fosfomycin resistance enzymes and represents the first of its type found in any Mycobacterium species. Genes encoding VOC fosfomycin resistance enzymes have been found in both Gram-positive and Gram-negative pathogens. Given that FosA enzymes from Gram-negative bacteria have evolved optimum activity towards glutathione (GSH) and FosB enzymes from Gram-positive bacteria have evolved optimum activity towards bacillithiol (BSH), it was originally suggested that FosM might represent a fourth class of enzyme that has evolved to utilize mycothiol (MSH). However, a sequence similarity network (SSN) analysis identifies FosM as a member of the FosX subfamily, indicating that it may utilize water as a substrate. Here we have synthesized MSH and characterized FosM with respect to divalent metal ion activation and nucleophile selectivity. Our results indicate that FosM is a Mn-dependent FosX-type hydrase with no selectivity toward MSH or other thiols as analyzed by NMR and mass spectroscopy.

Citing Articles

An objective criterion to evaluate sequence-similarity networks helps in dividing the protein family sequence space.

Hornung B, Terrapon N PLoS Comput Biol. 2023; 19(8):e1010881.

PMID: 37585436 PMC: 10461819. DOI: 10.1371/journal.pcbi.1010881.


Small molecule inhibitors of the fosfomycin resistance enzyme FosM from Mycobacterium abscessus.

Chiasson S, Smith T, Bello L, Chandrika N, Green K, Garneau-Tsodikova S Biochim Biophys Acta Gen Subj. 2023; 1867(10):130444.

PMID: 37579984 PMC: 10727124. DOI: 10.1016/j.bbagen.2023.130444.


Structural and functional characterization of fosfomycin resistance conferred by FosB from Enterococcus faecium.

Wiltsie V, Travis S, Shay M, Simmons Z, Frantom P, Thompson M Protein Sci. 2021; 31(3):580-590.

PMID: 34882867 PMC: 8862413. DOI: 10.1002/pro.4253.

References
1.
Adekambi T, Berger P, Raoult D, Drancourt M . rpoB gene sequence-based characterization of emerging non-tuberculous mycobacteria with descriptions of Mycobacterium bolletii sp. nov., Mycobacterium phocaicum sp. nov. and Mycobacterium aubagnense sp. nov. Int J Syst Evol Microbiol. 2006; 56(Pt 1):133-43. DOI: 10.1099/ijs.0.63969-0. View

2.
Wallace Jr R, Brown B, Griffith D . Nosocomial outbreaks/pseudo-outbreaks caused by nontuberculous mycobacteria. Annu Rev Microbiol. 1999; 52:453-90. DOI: 10.1146/annurev.micro.52.1.453. View

3.
Shannon P, Markiel A, Ozier O, Baliga N, Wang J, Ramage D . Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003; 13(11):2498-504. PMC: 403769. DOI: 10.1101/gr.1239303. View

4.
Falagas M, Maraki S, Karageorgopoulos D, Kastoris A, Mavromanolakis E, Samonis G . Antimicrobial susceptibility of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Enterobacteriaceae isolates to fosfomycin. Int J Antimicrob Agents. 2009; 35(3):240-3. DOI: 10.1016/j.ijantimicag.2009.10.019. View

5.
Eschenburg S, Kabsch W, Healy M, Schonbrunn E . A new view of the mechanisms of UDP-N-acetylglucosamine enolpyruvyl transferase (MurA) and 5-enolpyruvylshikimate-3-phosphate synthase (AroA) derived from X-ray structures of their tetrahedral reaction intermediate states. J Biol Chem. 2003; 278(49):49215-22. DOI: 10.1074/jbc.M309741200. View